| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 4.06e-05 | 130 | 194 | 8 | GO:0005200 | |
| GeneOntologyMolecularFunction | polyamine transmembrane transporter activity | 1.41e-04 | 11 | 194 | 3 | GO:0015203 | |
| GeneOntologyMolecularFunction | neuropeptide Y receptor activity | 1.41e-04 | 11 | 194 | 3 | GO:0004983 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | RNF144A MARCHF2 TRIM49C TRIM77 HERC2 TRIM48 FBXW11 TRIM49 TRIM51 TRIM71 TRIM49B TRIM51G | 2.95e-04 | 372 | 194 | 12 | GO:0061630 |
| GeneOntologyMolecularFunction | Wnt-protein binding | 3.19e-04 | 34 | 194 | 4 | GO:0017147 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | RNF144A MARCHF2 TRIM49C TRIM77 HERC2 TRIM48 FBXW11 TRIM49 TRIM51 TRIM71 TRIM49B TRIM51G | 5.40e-04 | 398 | 194 | 12 | GO:0061659 |
| GeneOntologyMolecularFunction | Wnt receptor activity | 5.55e-04 | 17 | 194 | 3 | GO:0042813 | |
| GeneOntologyMolecularFunction | pancreatic polypeptide receptor activity | 5.56e-04 | 4 | 194 | 2 | GO:0001602 | |
| GeneOntologyMolecularFunction | transporter activity | GABRP SLC22A25 GJD2 PIEZO1 SLCO3A1 RYR2 CFHR4 SLC52A3 KCNH6 SCN3A SCNN1D CACNA1G GJA10 RFT1 SLC52A1 TMC1 SLC35A1 ATP13A5 MCOLN1 ATP13A2 SFXN5 SLC16A3 SLC22A16 LRP2 SLC25A47 | 7.46e-04 | 1289 | 194 | 25 | GO:0005215 |
| GeneOntologyBiologicalProcess | protein localization to vacuole | 1.77e-05 | 89 | 189 | 7 | GO:0072665 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | CLTCL1 PPP2R3B TUBA3E STOX1 CUL7 TRRAP NCAPG2 TUBA4A TUBA3C TUBA1B FBXL7 TUBA1A FBXW11 TICRR FZD3 TUBA3D TUBA1C APC DGKZ TRIM71 PPP2R1A PBRM1 CTDP1 BECN1 | 1.98e-05 | 1014 | 189 | 24 | GO:0000278 |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 4.36e-06 | 47 | 192 | 6 | GO:0031462 | |
| GeneOntologyCellularComponent | cullin-RING ubiquitin ligase complex | PRAMEF9 CUL7 FBXL4 FBXL7 ZSWIM4 PRAMEF11 FBXW11 PRAMEF15 ZSWIM6 PRAMEF4 | 2.77e-05 | 212 | 192 | 10 | GO:0031461 |
| GeneOntologyCellularComponent | microfibril | 2.04e-04 | 13 | 192 | 3 | GO:0001527 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle | 3.41e-04 | 101 | 192 | 6 | GO:0045334 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle membrane | 4.26e-04 | 147 | 192 | 7 | GO:0030665 | |
| GeneOntologyCellularComponent | ubiquitin ligase complex | PRAMEF9 RNF144A CUL7 FBXL4 FBXL7 ZSWIM4 PRAMEF11 FBXW11 PRAMEF15 ZSWIM6 PRAMEF4 | 4.30e-04 | 352 | 192 | 11 | GO:0000151 |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle membrane | 8.07e-04 | 79 | 192 | 5 | GO:0030669 | |
| Domain | Alpha_tubulin | 8.12e-11 | 9 | 189 | 6 | IPR002452 | |
| Domain | - | 3.42e-08 | 20 | 189 | 6 | 3.30.1330.20 | |
| Domain | - | 4.74e-08 | 21 | 189 | 6 | 1.10.287.600 | |
| Domain | Tubulin_C | 6.47e-08 | 22 | 189 | 6 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 6.47e-08 | 22 | 189 | 6 | IPR018316 | |
| Domain | - | 6.47e-08 | 22 | 189 | 6 | 3.40.50.1440 | |
| Domain | Tubulin_C | 6.47e-08 | 22 | 189 | 6 | SM00865 | |
| Domain | Tub_FtsZ_C | 8.68e-08 | 23 | 189 | 6 | IPR008280 | |
| Domain | Tubulin_C | 8.68e-08 | 23 | 189 | 6 | IPR023123 | |
| Domain | TUBULIN | 8.68e-08 | 23 | 189 | 6 | PS00227 | |
| Domain | Tubulin | 8.68e-08 | 23 | 189 | 6 | IPR000217 | |
| Domain | Tubulin | 8.68e-08 | 23 | 189 | 6 | SM00864 | |
| Domain | Tubulin_CS | 8.68e-08 | 23 | 189 | 6 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 1.15e-07 | 24 | 189 | 6 | IPR003008 | |
| Domain | Tubulin | 1.15e-07 | 24 | 189 | 6 | PF00091 | |
| Domain | FBN | 1.02e-06 | 3 | 189 | 3 | IPR011398 | |
| Domain | Frizzled_dom | 3.66e-06 | 24 | 189 | 5 | IPR020067 | |
| Domain | FZ | 3.66e-06 | 24 | 189 | 5 | PS50038 | |
| Domain | Fz | 3.66e-06 | 24 | 189 | 5 | PF01392 | |
| Domain | BBOX | 6.18e-06 | 69 | 189 | 7 | SM00336 | |
| Domain | - | 7.48e-06 | 71 | 189 | 7 | 4.10.45.10 | |
| Domain | ZF_BBOX | 1.66e-05 | 80 | 189 | 7 | PS50119 | |
| Domain | Znf_B-box | 1.80e-05 | 81 | 189 | 7 | IPR000315 | |
| Domain | TB | 3.46e-05 | 7 | 189 | 3 | PF00683 | |
| Domain | FRI | 4.34e-05 | 20 | 189 | 4 | SM00063 | |
| Domain | ARM-type_fold | HIP1 CLTCL1 USP9X CUL7 TRRAP NCAPG2 FOCAD TTC12 TAF6 MROH9 APC PPP2R1A CFAP69 | 4.34e-05 | 339 | 189 | 13 | IPR016024 |
| Domain | SPRY | 4.74e-05 | 94 | 189 | 7 | PF00622 | |
| Domain | SPRY_dom | 4.74e-05 | 94 | 189 | 7 | IPR003877 | |
| Domain | B30.2/SPRY | 5.07e-05 | 95 | 189 | 7 | IPR001870 | |
| Domain | B302_SPRY | 5.07e-05 | 95 | 189 | 7 | PS50188 | |
| Domain | - | 5.31e-05 | 21 | 189 | 4 | 1.10.2000.10 | |
| Domain | - | 5.50e-05 | 8 | 189 | 3 | 3.90.290.10 | |
| Domain | Butyrophylin | 7.60e-05 | 70 | 189 | 6 | IPR003879 | |
| Domain | TB_dom | 8.19e-05 | 9 | 189 | 3 | IPR017878 | |
| Domain | TB | 8.19e-05 | 9 | 189 | 3 | PS51364 | |
| Domain | zf-B_box | 8.90e-05 | 72 | 189 | 6 | PF00643 | |
| Domain | - | 9.09e-05 | 222 | 189 | 10 | 1.25.10.10 | |
| Domain | NPY4_rcpt | 1.02e-04 | 2 | 189 | 2 | IPR001933 | |
| Domain | cEGF | 1.28e-04 | 26 | 189 | 4 | PF12662 | |
| Domain | cEGF | 1.28e-04 | 26 | 189 | 4 | IPR026823 | |
| Domain | Frizzled | 1.59e-04 | 11 | 189 | 3 | IPR000539 | |
| Domain | Frizzled | 1.59e-04 | 11 | 189 | 3 | PF01534 | |
| Domain | Frizzled | 1.59e-04 | 11 | 189 | 3 | SM01330 | |
| Domain | EGF_CA | 2.38e-04 | 86 | 189 | 6 | PF07645 | |
| Domain | Cul7 | 3.04e-04 | 3 | 189 | 2 | PF11515 | |
| Domain | Riboflavin_transptr | 3.04e-04 | 3 | 189 | 2 | IPR009357 | |
| Domain | CPH_domain | 3.04e-04 | 3 | 189 | 2 | IPR021097 | |
| Domain | DUF1011 | 3.04e-04 | 3 | 189 | 2 | PF06237 | |
| Domain | ARM-like | 4.40e-04 | 270 | 189 | 10 | IPR011989 | |
| Domain | Znf_RING | RNF144A MARCHF2 TRIM49C TRIM77 TRIM48 TRIM49 TRIM51 TRIM71 RNF17 CGRRF1 TRIM49B | 5.04e-04 | 326 | 189 | 11 | IPR001841 |
| Domain | Frizzled/SFRP | 5.18e-04 | 16 | 189 | 3 | IPR015526 | |
| Domain | P5-ATPase | 6.03e-04 | 4 | 189 | 2 | PF12409 | |
| Domain | ZF_RING_1 | RNF144A TRIM49C TRIM77 TRIM48 TRIM49 TRIM51 TRIM71 RNF17 CGRRF1 TRIM49B | 7.86e-04 | 291 | 189 | 10 | PS00518 |
| Domain | ZF_RING_2 | RNF144A TRIM49C TRIM77 TRIM48 TRIM49 TRIM51 TRIM71 RNF17 CGRRF1 TRIM49B | 9.42e-04 | 298 | 189 | 10 | PS50089 |
| Domain | P-type_TPase_V | 9.98e-04 | 5 | 189 | 2 | IPR006544 | |
| Domain | Apc4_WD40_dom | 1.02e-03 | 20 | 189 | 3 | IPR024977 | |
| Domain | ANAPC4_WD40 | 1.02e-03 | 20 | 189 | 3 | PF12894 | |
| Domain | RING | RNF144A TRIM49C TRIM77 TRIM48 TRIM49 TRIM51 TRIM71 RNF17 CGRRF1 TRIM49B | 1.12e-03 | 305 | 189 | 10 | SM00184 |
| Domain | EGF_CA | 1.52e-03 | 122 | 189 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.65e-03 | 124 | 189 | 6 | IPR001881 | |
| Domain | ConA-like_dom | 1.78e-03 | 219 | 189 | 8 | IPR013320 | |
| Domain | Clathrin | 2.07e-03 | 7 | 189 | 2 | PF00637 | |
| Domain | APC_su10/DOC_dom | 2.07e-03 | 7 | 189 | 2 | IPR004939 | |
| Domain | DOC | 2.07e-03 | 7 | 189 | 2 | PS51284 | |
| Domain | ANAPC10 | 2.07e-03 | 7 | 189 | 2 | PF03256 | |
| Domain | APC10 | 2.07e-03 | 7 | 189 | 2 | SM01337 | |
| Domain | Clathrin_H-chain/VPS_repeat | 2.74e-03 | 8 | 189 | 2 | IPR000547 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | GJD2 CLTCL1 TUBA3E TUBA4A TUBA3C TUBA1B TUBA1A GJA10 TUBA3D TUBA1C | 7.02e-11 | 51 | 142 | 10 | M26972 |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 1.05e-10 | 38 | 142 | 9 | M14981 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 1.62e-10 | 17 | 142 | 7 | M47768 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 2.63e-10 | 18 | 142 | 7 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 4.13e-10 | 19 | 142 | 7 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 4.13e-10 | 19 | 142 | 7 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 6.30e-10 | 20 | 142 | 7 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 6.30e-10 | 20 | 142 | 7 | M47911 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 9.37e-10 | 21 | 142 | 7 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 9.37e-10 | 21 | 142 | 7 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 1.36e-09 | 22 | 142 | 7 | M47903 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 1.94e-09 | 23 | 142 | 7 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 1.94e-09 | 23 | 142 | 7 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 1.94e-09 | 23 | 142 | 7 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 2.72e-09 | 24 | 142 | 7 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.72e-09 | 24 | 142 | 7 | M47700 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | TUBA4A TUBA3C TUBA1B TUBA1A WDR35 TUBA3D TUBA1C DYNC2I1 WDR19 | 2.99e-09 | 54 | 142 | 9 | M27482 |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 3.75e-09 | 25 | 142 | 7 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 3.75e-09 | 25 | 142 | 7 | M47710 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 5.08e-09 | 26 | 142 | 7 | M9648 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 5.08e-09 | 26 | 142 | 7 | M47672 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 9.00e-09 | 28 | 142 | 7 | M47898 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 9.36e-09 | 43 | 142 | 8 | M47669 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 1.18e-08 | 29 | 142 | 7 | M27948 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 1.37e-08 | 45 | 142 | 8 | M47670 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 2.47e-08 | 32 | 142 | 7 | M29848 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 2.47e-08 | 32 | 142 | 7 | M27491 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 2.47e-08 | 32 | 142 | 7 | MM14730 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 3.11e-08 | 33 | 142 | 7 | M27297 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 3.11e-08 | 33 | 142 | 7 | M47901 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 4.50e-08 | 52 | 142 | 8 | MM15211 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 4.82e-08 | 35 | 142 | 7 | M47774 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | TUBA3E TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D FAAP20 TUBA1C PPP2R1A | 6.65e-08 | 76 | 142 | 9 | M48037 |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 2.16e-07 | 43 | 142 | 7 | M47773 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 2.55e-07 | 44 | 142 | 7 | MM14606 | |
| Pathway | REACTOME_AGGREPHAGY | 2.55e-07 | 44 | 142 | 7 | M29830 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 2.55e-07 | 44 | 142 | 7 | M27934 | |
| Pathway | KEGG_GAP_JUNCTION | 2.93e-07 | 90 | 142 | 9 | M4013 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 3.50e-07 | 46 | 142 | 7 | M27828 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 5.43e-07 | 17 | 142 | 5 | MM14731 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 5.47e-07 | 49 | 142 | 7 | M891 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 9.21e-07 | 76 | 142 | 8 | M27215 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 9.50e-07 | 53 | 142 | 7 | M27651 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.23e-06 | 55 | 142 | 7 | M39613 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.39e-06 | 56 | 142 | 7 | M2333 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.58e-06 | 57 | 142 | 7 | M27251 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 2.03e-06 | 113 | 142 | 9 | M27471 | |
| Pathway | REACTOME_KINESINS | 2.51e-06 | 61 | 142 | 7 | M977 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP9X RNF144A TUBA3E MDGA2 CUL7 TRRAP TUBA4A TUBA3C FBXL4 NOD2 TUBA1B FBN1 FBXL7 TUBA1A COG6 PGAP1 UMOD PLAUR HERC2 RFT1 FBXW11 ADAMTSL1 PIGK TUBA3D TUBA1C SLC35A1 APC POMT1 THSD7B ADAMTS12 THBS2 ARSF ASGR2 BECN1 | 2.84e-06 | 1475 | 142 | 34 | M19806 |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | TUBA3E TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D FAAP20 TUBA1C PPP2R1A BECN1 | 2.93e-06 | 151 | 142 | 10 | M550 |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 4.30e-06 | 66 | 142 | 7 | MM17074 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 4.67e-06 | 94 | 142 | 8 | M2843 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 4.67e-06 | 94 | 142 | 8 | MM14515 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 5.05e-06 | 95 | 142 | 8 | M6729 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | PPP2R3B TUBA3E TUBA4A TUBA3C TUBA1B FBXL7 TUBA1A FBXW11 TUBA3D TUBA1C PPP2R1A | 5.62e-06 | 200 | 142 | 11 | M864 |
| Pathway | REACTOME_CILIUM_ASSEMBLY | TUBA3E TUBA4A TUBA3C TUBA1B TUBA1A WDR35 TUBA3D TUBA1C DYNC2I1 WDR19 PPP2R1A | 5.90e-06 | 201 | 142 | 11 | M27472 |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 6.53e-06 | 27 | 142 | 5 | MM15549 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 6.53e-06 | 27 | 142 | 5 | MM15674 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 7.05e-06 | 71 | 142 | 7 | M39690 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 7.74e-06 | 72 | 142 | 7 | M26954 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 8.59e-06 | 102 | 142 | 8 | M27648 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 9.45e-06 | 29 | 142 | 5 | MM15219 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 1.07e-05 | 105 | 142 | 8 | MM15206 | |
| Pathway | WP_ALZHEIMERS_DISEASE | TUBA3E TUBA4A TUBA3C FZD7 TUBA1B TUBA1A FZD3 TUBA3D TUBA1C APC BECN1 FZD2 | 1.30e-05 | 261 | 142 | 12 | M42565 |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 1.44e-05 | 79 | 142 | 7 | M27743 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT5A_ROR_SIGNALING_PATHWAY | 1.63e-05 | 16 | 142 | 4 | M47823 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 2.06e-05 | 150 | 142 | 9 | M27440 | |
| Pathway | REACTOME_AGGREPHAGY | 2.83e-05 | 36 | 142 | 5 | MM15669 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 3.00e-05 | 121 | 142 | 8 | M872 | |
| Pathway | REACTOME_AUTOPHAGY | TUBA3E TUBA4A TUBA3C TUBA1B ATG4B TUBA1A TUBA3D TUBA1C BECN1 | 3.12e-05 | 158 | 142 | 9 | M27935 |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 3.25e-05 | 37 | 142 | 5 | MM15102 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 3.38e-05 | 90 | 142 | 7 | M29841 | |
| Pathway | REACTOME_ATTACHMENT_OF_GPI_ANCHOR_TO_UPAR | 3.40e-05 | 7 | 142 | 3 | MM14622 | |
| Pathway | REACTOME_ATTACHMENT_OF_GPI_ANCHOR_TO_UPAR | 3.40e-05 | 7 | 142 | 3 | M26984 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 4.22e-05 | 20 | 142 | 4 | MM1383 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 4.25e-05 | 127 | 142 | 8 | M27181 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | TUBA3E TUBA4A TUBA3C ADCY5 TUBA1B TUBA1A RASGRF2 TUBA3D TUBA1C TSPAN7 | 4.26e-05 | 205 | 142 | 10 | M752 |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | TUBA3E TUBA4A TUBA3C TUBA1B TUBA1A WDR35 TUBA3D TUBA1C POLRMT DYNC2I1 WDR19 PPP2R1A | 4.65e-05 | 297 | 142 | 12 | M27050 |
| Pathway | REACTOME_PROTEIN_FOLDING | 5.85e-05 | 98 | 142 | 7 | M776 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 6.16e-05 | 68 | 142 | 6 | MM14921 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | TUBA3E TUBA4A TUBA3C TUBA1B TUBA1A COG6 UMOD RFT1 TUBA3D TUBA1C SLC35A1 ASGR2 | 6.39e-05 | 307 | 142 | 12 | M894 |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 6.65e-05 | 100 | 142 | 7 | M27650 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | GJD2 TUBA3E TUBA4A TUBA3C ADCY5 TUBA1B KCNH6 TUBA1A GJA10 ALDH5A1 RASGRF2 TUBA3D TUBA1C TSPAN7 | 6.92e-05 | 411 | 142 | 14 | M735 |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 7.29e-05 | 137 | 142 | 8 | MM15182 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 7.67e-05 | 138 | 142 | 8 | MM15635 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 8.49e-05 | 140 | 142 | 8 | M27550 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | TUBA3E TUBA4A TUBA3C ADCY5 TUBA1B TUBA1A ALDH5A1 RASGRF2 TUBA3D TUBA1C TSPAN7 | 9.02e-05 | 270 | 142 | 11 | M15514 |
| Pathway | REACTOME_INTERFERON_SIGNALING | TUBA3E TUBA4A TUBA3C TUBA1B TUBA1A TRIM48 TUBA3D FAAP20 TUBA1C PPP2R1A BECN1 | 9.96e-05 | 273 | 142 | 11 | M983 |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | PPP2R3B TUBA4A TUBA1B FBXL7 TUBA1A FBXW11 TUBA3D TUBA1C PPP2R1A | 1.02e-04 | 184 | 142 | 9 | MM15145 |
| Pathway | WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS | TUBA3E TUBA4A TUBA3C FZD7 TUBA1B TUBA1A FZD3 TUBA3D TUBA1C APC BECN1 FZD2 | 1.13e-04 | 326 | 142 | 12 | M39379 |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.17e-04 | 48 | 142 | 5 | MM15353 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.72e-04 | 52 | 142 | 5 | MM14949 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 1.80e-04 | 156 | 142 | 8 | M27097 | |
| Pathway | REACTOME_MEMBRANE_TRAFFICKING | HIP1 GJD2 CLTCL1 TUBA3E CHRM2 TUBA4A TUBA3C TUBA1B TUBA1A COG6 GJA10 TUBA3D TUBA1C VPS54 RIN1 CD3D LRP2 | 2.01e-04 | 630 | 142 | 17 | M11480 |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 2.14e-04 | 203 | 142 | 9 | M27654 | |
| Pathway | REACTOME_KINESINS | 2.66e-04 | 57 | 142 | 5 | MM15714 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP9X RNF144A TRRAP TUBA4A FBXL4 NOD2 TUBA1B FBN1 FBXL7 TUBA1A COG6 PGAP1 UMOD PLAUR HERC2 FBXW11 ADAMTSL1 PIGK TUBA3D TUBA1C SLC35A1 APC POMT1 THSD7B ADAMTS12 THBS2 ASGR2 BECN1 | 2.67e-04 | 1389 | 142 | 28 | MM15307 |
| Pathway | WNT_SIGNALING | 2.75e-04 | 89 | 142 | 6 | M5493 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 2.83e-04 | 126 | 142 | 7 | M705 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 2.92e-04 | 90 | 142 | 6 | MM14979 | |
| Pubmed | 5.78e-15 | 9 | 196 | 7 | 21167302 | ||
| Pubmed | 7.71e-12 | 19 | 196 | 7 | 15698476 | ||
| Pubmed | 7.71e-12 | 19 | 196 | 7 | 15691386 | ||
| Pubmed | 2.57e-11 | 22 | 196 | 7 | 28117675 | ||
| Pubmed | 3.23e-11 | 6 | 196 | 5 | 3785200 | ||
| Pubmed | 1.42e-10 | 15 | 196 | 6 | 19703589 | ||
| Pubmed | Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. | 2.98e-10 | 8 | 196 | 5 | 16148047 | |
| Pubmed | Identification of a genomic reservoir for new TRIM genes in primate genomes. | 7.57e-10 | 19 | 196 | 6 | 22144910 | |
| Pubmed | 9.78e-10 | 4 | 196 | 4 | 18400243 | ||
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 2.05e-09 | 22 | 196 | 6 | 23826228 | |
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 4.14e-09 | 12 | 196 | 5 | 15331610 | |
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 6.70e-09 | 13 | 196 | 5 | 10908577 | |
| Pubmed | 1.04e-08 | 14 | 196 | 5 | 12486001 | ||
| Pubmed | The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. | 1.45e-08 | 6 | 196 | 4 | 7651436 | |
| Pubmed | 1.45e-08 | 6 | 196 | 4 | 16327313 | ||
| Pubmed | 3.16e-08 | 17 | 196 | 5 | 17360745 | ||
| Pubmed | 3.38e-08 | 7 | 196 | 4 | 36681692 | ||
| Pubmed | 3.38e-08 | 7 | 196 | 4 | 11146551 | ||
| Pubmed | Interaction between metabotropic glutamate receptor 7 and alpha tubulin. | 1.21e-07 | 9 | 196 | 4 | 11953448 | |
| Pubmed | 1.32e-07 | 22 | 196 | 5 | 15103018 | ||
| Pubmed | 1.76e-07 | 3 | 196 | 3 | 11163133 | ||
| Pubmed | 1.76e-07 | 3 | 196 | 3 | 11121746 | ||
| Pubmed | Tubulin and FtsZ structures: functional and therapeutic implications. | 1.76e-07 | 3 | 196 | 3 | 9722999 | |
| Pubmed | Lineage-specific biology revealed by a finished genome assembly of the mouse. | 6.84e-07 | 55 | 196 | 6 | 19468303 | |
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 7.02e-07 | 4 | 196 | 3 | 25034023 | |
| Pubmed | Ror2 modulates the canonical Wnt signaling in lung epithelial cells through cooperation with Fzd2. | 7.02e-07 | 4 | 196 | 3 | 18215320 | |
| Pubmed | Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling. | 3.48e-06 | 6 | 196 | 3 | 20802536 | |
| Pubmed | 3.48e-06 | 6 | 196 | 3 | 18613978 | ||
| Pubmed | 3.48e-06 | 6 | 196 | 3 | 12090300 | ||
| Pubmed | 6.07e-06 | 7 | 196 | 3 | 1846368 | ||
| Pubmed | 9.67e-06 | 8 | 196 | 3 | 22326026 | ||
| Pubmed | 9.67e-06 | 8 | 196 | 3 | 19388021 | ||
| Pubmed | Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL). | 1.23e-05 | 247 | 196 | 9 | 39238192 | |
| Pubmed | 1.25e-05 | 90 | 196 | 6 | 19515997 | ||
| Pubmed | USP9X ASH1L FOCAD TUBA1B FBN1 NAV3 PLAUR HERC2 TAF6 ALDH5A1 MED13 FBXW11 APC TTC27 APEH DYNC2I1 VPS54 WDR19 TSPAN7 LRP2 BECN1 | 1.34e-05 | 1285 | 196 | 21 | 35914814 | |
| Pubmed | 1.44e-05 | 9 | 196 | 3 | 19103752 | ||
| Pubmed | A novel frizzled gene identified in human esophageal carcinoma mediates APC/beta-catenin signals. | 1.44e-05 | 9 | 196 | 3 | 9707618 | |
| Pubmed | 1.94e-05 | 58 | 196 | 5 | 27869233 | ||
| Pubmed | Expression of Frizzled genes in developing and postnatal hair follicles. | 2.05e-05 | 10 | 196 | 3 | 15245425 | |
| Pubmed | Essential roles of mesenchyme-derived beta-catenin in mouse Müllerian duct morphogenesis. | 2.05e-05 | 10 | 196 | 3 | 17532316 | |
| Pubmed | 2.11e-05 | 59 | 196 | 5 | 11279525 | ||
| Pubmed | Frizzled-9 impairs acetylcholine receptor clustering in skeletal muscle cells. | 2.81e-05 | 11 | 196 | 3 | 24860427 | |
| Pubmed | Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle. | 2.81e-05 | 11 | 196 | 3 | 20405035 | |
| Pubmed | Molecular determinants of WNT9b responsiveness in nephron progenitor cells. | 2.81e-05 | 11 | 196 | 3 | 30978219 | |
| Pubmed | 2.81e-05 | 11 | 196 | 3 | 17576136 | ||
| Pubmed | Ubiquitin ligase TRIM71 suppresses ovarian tumorigenesis by degrading mutant p53. | 2.81e-05 | 11 | 196 | 3 | 31570706 | |
| Pubmed | 2.81e-05 | 11 | 196 | 3 | 17582687 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 12399449 | ||
| Pubmed | Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release. | 3.16e-05 | 2 | 196 | 2 | 21743453 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 21851253 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 23413253 | ||
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 3.16e-05 | 2 | 196 | 2 | 30044367 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 3.16e-05 | 2 | 196 | 2 | 21440062 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 15131124 | ||
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 3.16e-05 | 2 | 196 | 2 | 20404337 | |
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 3.16e-05 | 2 | 196 | 2 | 8791520 | |
| Pubmed | Acetylated α-tubulin is reduced in individuals with poor sperm motility. | 3.16e-05 | 2 | 196 | 2 | 24268707 | |
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 3.16e-05 | 2 | 196 | 2 | 8307578 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 24244602 | ||
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 3.16e-05 | 2 | 196 | 2 | 7744963 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 34763008 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 26408953 | ||
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 3.16e-05 | 2 | 196 | 2 | 18006876 | |
| Pubmed | Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. | 3.16e-05 | 2 | 196 | 2 | 24833718 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 24265020 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 20529844 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 23133647 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 25328666 | ||
| Pubmed | Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. | 3.16e-05 | 2 | 196 | 2 | 1852206 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 12054644 | ||
| Pubmed | Mieap suppresses murine intestinal tumor via its mitochondrial quality control. | 3.16e-05 | 2 | 196 | 2 | 26216032 | |
| Pubmed | Structural features and restricted expression of a human alpha-tubulin gene. | 3.16e-05 | 2 | 196 | 2 | 3839072 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 12429739 | ||
| Pubmed | Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. | 3.16e-05 | 2 | 196 | 2 | 12524050 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 24115398 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 8120105 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 35419902 | ||
| Pubmed | Fibrillin assembly: dimer formation mediated by amino-terminal sequences. | 3.16e-05 | 2 | 196 | 2 | 10504303 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 15221638 | ||
| Pubmed | Immunohistochemical expression of fibrillin-1 and fibrillin-2 during tooth development. | 3.16e-05 | 2 | 196 | 2 | 25524144 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 22296162 | ||
| Pubmed | Fibrillins 1 and 2 perform partially overlapping functions during aortic development. | 3.16e-05 | 2 | 196 | 2 | 16407178 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 10359653 | ||
| Pubmed | 4.84e-05 | 13 | 196 | 3 | 14697242 | ||
| Pubmed | 7.21e-05 | 76 | 196 | 5 | 27542412 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | TCAF1 CLTCL1 USP9X CUL7 TUBA4A TUBA3C TUBA1B TUBA1A HERC2 TUBA1C APC PPP2R1A PBRM1 | 7.57e-05 | 639 | 196 | 13 | 23443559 |
| Pubmed | 7.63e-05 | 40 | 196 | 4 | 30865227 | ||
| Pubmed | 7.63e-05 | 15 | 196 | 3 | 15617677 | ||
| Pubmed | Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors. | 7.98e-05 | 125 | 196 | 6 | 36030824 | |
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 10825173 | ||
| Pubmed | Identification of alpha-tubulin as an hsp105alpha-binding protein by the yeast two-hybrid system. | 9.44e-05 | 3 | 196 | 2 | 12749852 | |
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 31767681 | ||
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 12087096 | ||
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 9813155 | ||
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 26976849 | ||
| Pubmed | The Expression of Riboflavin Transporters in Human Colorectal Cancer. | 9.44e-05 | 3 | 196 | 2 | 29715086 | |
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 17681699 | ||
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 30201140 | ||
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 26072523 | ||
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 23506902 | ||
| Interaction | TCP11L2 interactions | 3.13e-08 | 21 | 190 | 6 | int:TCP11L2 | |
| Interaction | LTA interactions | 5.82e-06 | 28 | 190 | 5 | int:LTA | |
| Cytoband | 1p36.21 | 1.58e-04 | 63 | 196 | 4 | 1p36.21 | |
| GeneFamily | Tubulins | 9.69e-10 | 26 | 143 | 7 | 778 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 8.56e-07 | 95 | 143 | 8 | 59 | |
| GeneFamily | Ring finger proteins | RNF144A MARCHF2 TRIM49C TRIM77 TRIM48 TRIM49 TRIM51 TRIM71 RNF17 CGRRF1 TRIM49B | 1.21e-05 | 275 | 143 | 11 | 58 |
| GeneFamily | PRAME family | 3.53e-05 | 24 | 143 | 4 | 686 | |
| GeneFamily | G protein-coupled receptors, Class F frizzled | 7.63e-05 | 11 | 143 | 3 | 286 | |
| GeneFamily | Parkinson disease associated genes|ATPase orphan transporters | 6.12e-04 | 5 | 143 | 2 | 1213 | |
| GeneFamily | Zinc fingers SWIM-type|Mitogen-activated protein kinase kinase kinases | 2.16e-03 | 9 | 143 | 2 | 90 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-06 | 191 | 196 | 8 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-06 | 192 | 196 | 8 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-06 | 192 | 196 | 8 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.71e-06 | 197 | 196 | 8 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 2.92e-06 | 199 | 196 | 8 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-06 | 200 | 196 | 8 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-06 | 200 | 196 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 6.82e-06 | 159 | 196 | 7 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-05 | 172 | 196 | 7 | da959c1abadafd79b7a0088a25eb8ef8efa3a0c2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.18e-05 | 173 | 196 | 7 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.27e-05 | 175 | 196 | 7 | 9941c35601134d88d1b3249c81f8b43a8fc61610 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.37e-05 | 177 | 196 | 7 | 1921226196b2ab7919d9f843e60d9f4bd9ec9c57 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 178 | 196 | 7 | 09a215a0d6e98e4bb920cabda12af08ff4de3c98 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.59e-05 | 181 | 196 | 7 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-05 | 183 | 196 | 7 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 1.83e-05 | 185 | 196 | 7 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.96e-05 | 187 | 196 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.17e-05 | 190 | 196 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-05 | 191 | 196 | 7 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.24e-05 | 191 | 196 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-05 | 191 | 196 | 7 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.32e-05 | 192 | 196 | 7 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.32e-05 | 192 | 196 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-05 | 192 | 196 | 7 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.40e-05 | 193 | 196 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.40e-05 | 193 | 196 | 7 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-05 | 194 | 196 | 7 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 2.48e-05 | 194 | 196 | 7 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-05 | 194 | 196 | 7 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-05 | 195 | 196 | 7 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 2.64e-05 | 196 | 196 | 7 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 2.64e-05 | 196 | 196 | 7 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.64e-05 | 196 | 196 | 7 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-05 | 197 | 196 | 7 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 2.73e-05 | 197 | 196 | 7 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 2.82e-05 | 198 | 196 | 7 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 2.82e-05 | 198 | 196 | 7 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.82e-05 | 198 | 196 | 7 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 2.91e-05 | 199 | 196 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.01e-05 | 200 | 196 | 7 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.01e-05 | 200 | 196 | 7 | 25f4c051c2e869481f33c22ad54de97efac444ad | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Interneuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 3.01e-05 | 200 | 196 | 7 | a6500d0d2e8bcac92381ab771dbdee66b0e1d48e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial-Proteoglycan-expressing_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.01e-05 | 200 | 196 | 7 | da45a85a4667965b24ba824af871157af5b4cd19 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.01e-05 | 200 | 196 | 7 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.01e-05 | 200 | 196 | 7 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | control-HLA-DR-_S100A+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.01e-05 | 200 | 196 | 7 | 107a0665fb20247511a430178effd7630a619488 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.01e-05 | 200 | 196 | 7 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Tracheal-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.01e-05 | 200 | 196 | 7 | 9d3ae9ea47b1017adb63aa02d10e98193d478458 | |
| ToppCell | Tracheal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.01e-05 | 200 | 196 | 7 | 78cd0b7d221ef855512ee9ac9a291f61622c2e24 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.01e-05 | 200 | 196 | 7 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | control-HLA-DR-_S100A+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.01e-05 | 200 | 196 | 7 | 9e3e13a68bc1110fa000ec2d80f4c654ddbce17e | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr-Polydendrocyte.Tnr.Opalin_(Opalin)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.10e-05 | 82 | 196 | 5 | 5cd8e47edb775eabf3e9a407c1c2d8a78afb9509 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.10e-05 | 82 | 196 | 5 | 1eeb259ec555879ee1962b7bc2c31c200fbb85cf | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Embryonal_Carcinoma|TCGA-Testes / Sample_Type by Project: Shred V9 | 3.52e-05 | 139 | 196 | 6 | 6b58d01ce9d9ac23434333f9faf1bb0eef14ba90 | |
| ToppCell | tumor_Lung-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 3.96e-05 | 142 | 196 | 6 | eaf08a0dbacc9ebbd54e377922e76d8ba854dcb8 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.28e-05 | 144 | 196 | 6 | 9d6133558728fa148050eb4f0be33756d71310b0 | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 4.99e-05 | 148 | 196 | 6 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr-Polydendrocyte.Tnr.Pdgfa_(Pdgfa)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.12e-05 | 91 | 196 | 5 | 4d84281e8e3236c687b910cd76de836b70dafdb7 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P1-P1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.12e-05 | 91 | 196 | 5 | 83564e9e4122c176a28c30b0c2546c82185ddaa6 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.12e-05 | 91 | 196 | 5 | ff6022b23e9bd8af24bcb658ae2b48eae6bf1e28 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 7.29e-05 | 98 | 196 | 5 | fca0baf13520c53edb6da2fe3eb152fbd44df5ed | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.96e-05 | 161 | 196 | 6 | b81b346309f3facbfbebd91cae4c5b33c7bd24ef | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-2|TCGA-Cervix / Sample_Type by Project: Shred V9 | 8.03e-05 | 100 | 196 | 5 | 309e1600d21f3be97b48d183306b9115eb75e6a3 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.82e-05 | 164 | 196 | 6 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.82e-05 | 164 | 196 | 6 | 467ad12884b70d243988174ae960ee2b7b6cfb0c | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-Ly6g5b+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.82e-05 | 164 | 196 | 6 | 4e1861382c9e93856da19303474c8975c19706d2 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.11e-05 | 165 | 196 | 6 | a6c6de17fec678ad0cac3138dde3a14cc39ffd26 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-immature_innate_lymphoid_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.74e-05 | 167 | 196 | 6 | 5d1919bea8e5a52ac6fc953caff15509b7142923 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-immature_innate_lymphoid_cell-Ly6g5b+_T|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.74e-05 | 167 | 196 | 6 | d8f497860d48342a3aaaad328f88e4d55ab4faeb | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 169 | 196 | 6 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-04 | 169 | 196 | 6 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-04 | 169 | 196 | 6 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 170 | 196 | 6 | 2b5b1f8d13b9806b76b44a53f47a23dd9ff09808 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Ly6g5b+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 170 | 196 | 6 | 43c48267d8291c88263148a36fbb63c27f0e4f1c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-04 | 171 | 196 | 6 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 174 | 196 | 6 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-B_cells-CLP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.30e-04 | 176 | 196 | 6 | f163cc6d632112aad35a0a9217c6c99fbdd1386e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.38e-04 | 178 | 196 | 6 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.42e-04 | 179 | 196 | 6 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.47e-04 | 180 | 196 | 6 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.47e-04 | 180 | 196 | 6 | 392bc71a69653ba12de31bed4e9357f181094641 | |
| ToppCell | MS-Treg-naive_CD4|MS / Condition, Cell_class and T cell subcluster | 1.47e-04 | 180 | 196 | 6 | 7ca083616926d98420fa11a6e5ebc981623f79ac | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.51e-04 | 181 | 196 | 6 | 8fd64404e57c22c204d835fc5626f73554257b19 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-04 | 181 | 196 | 6 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | Pericytes-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.51e-04 | 181 | 196 | 6 | ff445a8e56522e57e27405184d123cf905caf8cc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-04 | 184 | 196 | 6 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.65e-04 | 184 | 196 | 6 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 185 | 196 | 6 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-04 | 185 | 196 | 6 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.70e-04 | 185 | 196 | 6 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 185 | 196 | 6 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 185 | 196 | 6 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-04 | 185 | 196 | 6 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-8|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.75e-04 | 118 | 196 | 5 | e3dca31f47324ee207b773145475147fe3e761fe | |
| ToppCell | megakaryocytic-Megakaryocyte|World / Lineage and Cell class | 1.75e-04 | 186 | 196 | 6 | acd15a169b6122b28cc99ef34de10701edcfedfe | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-04 | 187 | 196 | 6 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.80e-04 | 187 | 196 | 6 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.80e-04 | 187 | 196 | 6 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-04 | 187 | 196 | 6 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.80e-04 | 187 | 196 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| Drug | Epothilone D | 2.98e-08 | 12 | 191 | 5 | DB01873 | |
| Drug | Epothilone B | 2.98e-08 | 12 | 191 | 5 | DB03010 | |
| Drug | procaine | GABRP TUBA3E CHRM2 TUBA4A RYR2 TUBA1A SCN3A SCNN1D CACNA1G TUBA1C | 6.93e-07 | 153 | 191 | 10 | CID000004914 |
| Drug | 2,4-dichlorobenzyl thiocyanate | 9.25e-07 | 22 | 191 | 5 | CID000098538 | |
| Drug | 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE | 2.31e-06 | 4 | 191 | 3 | DB07574 | |
| Drug | L-quisqualic acid | GABRP TUBA3E CHRM2 TUBA4A ADCY5 TUBA1A TRIM49 TUBA1C APEH TRIM49B | 3.03e-06 | 180 | 191 | 10 | CID000001209 |
| Drug | AC1NBBHE | 4.74e-06 | 30 | 191 | 5 | CID004490620 | |
| Drug | 3,4-dimethylhexane-2,5-dione | 5.61e-06 | 31 | 191 | 5 | CID000032851 | |
| Drug | tropone | 5.61e-06 | 31 | 191 | 5 | CID000010881 | |
| Drug | mebendazole | 7.73e-06 | 33 | 191 | 5 | CID000004030 | |
| Drug | AAGTP | 1.61e-05 | 64 | 191 | 6 | CID000656407 | |
| Drug | bromocolchicine | 2.57e-05 | 21 | 191 | 4 | CID000161518 | |
| Drug | colchifoline | 2.57e-05 | 21 | 191 | 4 | CID000100132 | |
| Drug | Ustiloxin A | 2.57e-05 | 21 | 191 | 4 | CID000164454 | |
| Drug | SRI-3072 | 2.57e-05 | 21 | 191 | 4 | CID000493469 | |
| Drug | 3,4,5-trimethoxyacetophenone | 3.12e-05 | 22 | 191 | 4 | CID000014345 | |
| Drug | AC1L1GIQ | 3.12e-05 | 22 | 191 | 4 | CID000003700 | |
| Drug | SureCN13401588 | 3.12e-05 | 22 | 191 | 4 | CID009897422 | |
| Drug | N-methyldemecolcine | 3.12e-05 | 22 | 191 | 4 | CID000023759 | |
| Drug | NSC-339672 | 3.12e-05 | 22 | 191 | 4 | CID000433930 | |
| Drug | methyl ether | 3.67e-05 | 45 | 191 | 5 | CID000008254 | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 3.75e-05 | 23 | 191 | 4 | CID000006858 | |
| Drug | AC1L2P05 | 3.75e-05 | 23 | 191 | 4 | CID000125688 | |
| Drug | 2,3,4-tabp | 3.75e-05 | 23 | 191 | 4 | CID000125548 | |
| Drug | NSC-373301 | 3.75e-05 | 23 | 191 | 4 | CID000341375 | |
| Drug | NSC355636 | 3.75e-05 | 23 | 191 | 4 | CID000100176 | |
| Drug | IKP104 | 3.75e-05 | 23 | 191 | 4 | CID000130739 | |
| Drug | fluorescein-colchicine | 3.75e-05 | 23 | 191 | 4 | CID003035871 | |
| Drug | 3-demethylthiocolchicine | 3.75e-05 | 23 | 191 | 4 | CID000084076 | |
| Drug | 2,3,4-TCB | 3.75e-05 | 23 | 191 | 4 | CID000129239 | |
| Drug | N-acetylcolchinol | 3.75e-05 | 23 | 191 | 4 | CID000097865 | |
| Drug | parbendazole | 4.47e-05 | 24 | 191 | 4 | CID000026596 | |
| Drug | tropolone methyl ether | 4.47e-05 | 24 | 191 | 4 | CID000016546 | |
| Drug | 7-epi-cephalomannine | 4.47e-05 | 24 | 191 | 4 | CID000330401 | |
| Drug | NABV | 4.47e-05 | 24 | 191 | 4 | CID000175959 | |
| Drug | AC1L4TG7 | 4.47e-05 | 24 | 191 | 4 | CID000163705 | |
| Drug | moscatilin | 4.47e-05 | 24 | 191 | 4 | CID000176096 | |
| Drug | NSC-36768 | 4.47e-05 | 24 | 191 | 4 | CID000165441 | |
| Drug | deacetamidocolchicine | 4.47e-05 | 24 | 191 | 4 | CID000014995 | |
| Drug | colchicide | 4.47e-05 | 24 | 191 | 4 | CID000120712 | |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | CLTCL1 PIEZO1 RO60 FBXW11 TTC27 DYNC2I1 PPP2R1A RPUSD2 DOP1A | 4.50e-05 | 197 | 191 | 9 | 1148_DN |
| Drug | 3-nitropropionic acid; Up 200; 10uM; MCF7; HT_HG-U133A | 4.50e-05 | 197 | 191 | 9 | 6367_UP | |
| Drug | tryprostatin A | 5.04e-05 | 48 | 191 | 5 | CID009929833 | |
| Drug | mpMap | 5.29e-05 | 25 | 191 | 4 | CID000100806 | |
| Drug | AC1Q6P06 | 5.29e-05 | 25 | 191 | 4 | CID000160263 | |
| Drug | allocolchicine | 5.29e-05 | 25 | 191 | 4 | CID000196989 | |
| Drug | 1069C85 | 5.29e-05 | 25 | 191 | 4 | CID006918099 | |
| Drug | 55623-37-5 | 5.29e-05 | 25 | 191 | 4 | CID006438440 | |
| Drug | MDL 27048 | 5.29e-05 | 25 | 191 | 4 | CID006439188 | |
| Drug | NBD-colcemid | 5.29e-05 | 25 | 191 | 4 | CID000130594 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 5.29e-05 | 25 | 191 | 4 | CID000043264 | |
| Drug | CA1P | 5.29e-05 | 25 | 191 | 4 | CID006918545 | |
| Drug | peloruside A | 5.29e-05 | 25 | 191 | 4 | CID006918506 | |
| Drug | NSC142227 | 5.29e-05 | 25 | 191 | 4 | CID000073427 | |
| Drug | NSC527981 | 6.21e-05 | 26 | 191 | 4 | CID000352796 | |
| Drug | NSC332029 | 6.21e-05 | 26 | 191 | 4 | CID000100073 | |
| Drug | indibulin | 6.21e-05 | 26 | 191 | 4 | CID000002929 | |
| Drug | pironetin | 6.21e-05 | 26 | 191 | 4 | CID006438891 | |
| Drug | isaxonine | 6.21e-05 | 26 | 191 | 4 | CID000071169 | |
| Drug | AC1L1J4H | 7.24e-05 | 27 | 191 | 4 | CID000004862 | |
| Drug | dinitroanilines | 7.24e-05 | 27 | 191 | 4 | CID000136400 | |
| Drug | NSC292222 | 7.24e-05 | 27 | 191 | 4 | CID000099957 | |
| Drug | NSC D-669356 | 7.24e-05 | 27 | 191 | 4 | CID000178028 | |
| Drug | NSC 370147 | 8.39e-05 | 28 | 191 | 4 | CID000182762 | |
| Drug | NSC72302 | 8.39e-05 | 28 | 191 | 4 | CID000118078 | |
| Drug | bp U | 9.67e-05 | 29 | 191 | 4 | CID000368697 | |
| Drug | oxibendazole | 9.67e-05 | 29 | 191 | 4 | CID000004622 | |
| Drug | Aids106696 | 9.67e-05 | 29 | 191 | 4 | CID006475933 | |
| Drug | ddGDP | 9.67e-05 | 29 | 191 | 4 | CID000134739 | |
| Drug | eleutherobin | 1.11e-04 | 30 | 191 | 4 | CID006918335 | |
| Drug | azatoxin | 1.11e-04 | 30 | 191 | 4 | CID000125383 | |
| Drug | NSC617668 | 1.11e-04 | 30 | 191 | 4 | CID000357989 | |
| Drug | citostal | 1.11e-04 | 30 | 191 | 4 | CID000018991 | |
| Drug | thiocolchicine | 1.11e-04 | 30 | 191 | 4 | CID000017648 | |
| Drug | NSC609395 | 1.26e-04 | 31 | 191 | 4 | CID005488798 | |
| Drug | amiprophosmethyl | 1.26e-04 | 31 | 191 | 4 | CID000100524 | |
| Drug | AC7700 | 1.26e-04 | 31 | 191 | 4 | CID006918404 | |
| Drug | AC1L3V8I | 1.26e-04 | 31 | 191 | 4 | CID000122777 | |
| Drug | NSC332598 | 1.26e-04 | 31 | 191 | 4 | CID000615942 | |
| Drug | N,N'-ethylenebis(iodoacetamide | 1.26e-04 | 31 | 191 | 4 | CID000023678 | |
| Drug | AC1L1G95 | 1.44e-04 | 32 | 191 | 4 | CID000003583 | |
| Drug | NSC153858 | 1.44e-04 | 32 | 191 | 4 | CID000547450 | |
| Drug | E2-3,4-Q | 1.44e-04 | 32 | 191 | 4 | CID000067402 | |
| Drug | 2-demethylcolchicine | 1.44e-04 | 32 | 191 | 4 | CID000023757 | |
| Drug | CA4P | 1.62e-04 | 33 | 191 | 4 | CID000370232 | |
| Drug | taltobulin | 1.62e-04 | 33 | 191 | 4 | CID006918637 | |
| Drug | triethyllead | 1.83e-04 | 34 | 191 | 4 | CID006328106 | |
| Drug | NSC376450 | 1.83e-04 | 34 | 191 | 4 | CID000005605 | |
| Drug | 2-phenyl-4-quinolone | 1.83e-04 | 34 | 191 | 4 | CID000161091 | |
| Drug | tubulin polymerization inhibitor | 2.01e-04 | 142 | 191 | 7 | CID010125800 | |
| Drug | discodermolide | 2.05e-04 | 35 | 191 | 4 | CID000643668 | |
| Drug | Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 2.33e-04 | 193 | 191 | 8 | 3845_UP | |
| Drug | AC1O5Y0F | 2.55e-04 | 37 | 191 | 4 | CID006442852 | |
| Drug | DTAF | 2.55e-04 | 37 | 191 | 4 | CID000123934 | |
| Drug | albendazole | 2.55e-04 | 37 | 191 | 4 | CID000002082 | |
| Drug | baccatin III | 2.55e-04 | 37 | 191 | 4 | CID000065366 | |
| Drug | Amiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; HL60; HT_HG-U133A | 2.68e-04 | 197 | 191 | 8 | 3000_UP | |
| Drug | Diethylcarbamazine citrate [1642-54-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 2.68e-04 | 197 | 191 | 8 | 7425_DN | |
| Drug | Oxaprozin [21256-18-8]; Down 200; 13.6uM; PC3; HT_HG-U133A | 2.68e-04 | 197 | 191 | 8 | 4530_DN | |
| Drug | Cefotetan [69712-56-7]; Down 200; 7uM; MCF7; HT_HG-U133A | 2.77e-04 | 198 | 191 | 8 | 4116_DN | |
| Disease | microlissencephaly (implicated_via_orthology) | 3.03e-15 | 8 | 188 | 7 | DOID:0112234 (implicated_via_orthology) | |
| Disease | lissencephaly 3 (implicated_via_orthology) | 3.03e-15 | 8 | 188 | 7 | DOID:0112232 (implicated_via_orthology) | |
| Disease | polymicrogyria (implicated_via_orthology) | 3.03e-15 | 8 | 188 | 7 | DOID:0080918 (implicated_via_orthology) | |
| Disease | lissencephaly (implicated_via_orthology) | 3.04e-10 | 27 | 188 | 7 | DOID:0050453 (implicated_via_orthology) | |
| Disease | connective tissue disease (implicated_via_orthology) | 2.55e-07 | 3 | 188 | 3 | DOID:65 (implicated_via_orthology) | |
| Disease | multiple system atrophy | 5.47e-06 | 40 | 188 | 5 | EFO_1001050 | |
| Disease | Intellectual Disability | ASH1L TRRAP TUBA1A SCN3A CACNA1G TAF6 ALDH5A1 MED13 FBXW11 APC PPP2R1A LRP2 | 3.26e-05 | 447 | 188 | 12 | C3714756 |
| Disease | lower face morphology measurement | 7.26e-05 | 109 | 188 | 6 | EFO_0010948 | |
| Disease | Brown-Vialetto-Van Laere syndrome (implicated_via_orthology) | 1.21e-04 | 3 | 188 | 2 | DOID:0050694 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | STOX1 PLXNB2 CPED1 FOCAD FBN1 FBN2 FBXL7 TUBA1A NAV3 AFF1 ZSWIM4 SMG6 TICRR ADAMTSL1 FZD3 TUBA1C APC TRIM71 MSH5 ATP13A2 FBN3 | 1.45e-04 | 1345 | 188 | 21 | EFO_0010736 |
| Disease | scoliosis (is_implicated_in) | 2.40e-04 | 4 | 188 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | Gastrointestinal Neoplasms | 2.40e-04 | 4 | 188 | 2 | C0017185 | |
| Disease | Malignant neoplasm of gastrointestinal tract | 2.40e-04 | 4 | 188 | 2 | C0685938 | |
| Disease | juvenile-onset Parkinson's disease (implicated_via_orthology) | 2.40e-04 | 4 | 188 | 2 | DOID:0060893 (implicated_via_orthology) | |
| Disease | Cranioectodermal dysplasia | 2.40e-04 | 4 | 188 | 2 | cv:C4551571 | |
| Disease | Kufor-Rakeb syndrome (implicated_via_orthology) | 2.40e-04 | 4 | 188 | 2 | DOID:0060556 (implicated_via_orthology) | |
| Disease | lissencephaly (is_implicated_in) | 3.99e-04 | 5 | 188 | 2 | DOID:0050453 (is_implicated_in) | |
| Disease | CRANIOECTODERMAL DYSPLASIA 1 | 3.99e-04 | 5 | 188 | 2 | C0432235 | |
| Disease | Short rib-polydactyly syndrome, Verma-Naumoff type | 3.99e-04 | 5 | 188 | 2 | C0432197 | |
| Disease | eye colour measurement | 5.19e-04 | 218 | 188 | 7 | EFO_0009764 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 5.26e-04 | 157 | 188 | 6 | DOID:14330 (implicated_via_orthology) | |
| Disease | response to iloperidone | 5.96e-04 | 6 | 188 | 2 | GO_0036287 | |
| Disease | Glycosuria | 8.30e-04 | 7 | 188 | 2 | HP_0003076 | |
| Disease | Abnormality of the eye | 8.30e-04 | 7 | 188 | 2 | C4316870 | |
| Disease | perinatal necrotizing enterocolitis (is_marker_for) | 8.30e-04 | 7 | 188 | 2 | DOID:8677 (is_marker_for) | |
| Disease | acute lymphoblastic leukemia | 8.45e-04 | 66 | 188 | 4 | EFO_0000220 | |
| Disease | scavenger receptor cysteine-rich type 1 protein m130 measurement | 1.41e-03 | 9 | 188 | 2 | EFO_0020717 | |
| Disease | Disproportionate short stature | 1.50e-03 | 77 | 188 | 4 | C0878659 | |
| Disease | pulse pressure measurement | HIP1 PLXNB2 CHRM2 ADCY5 FBN1 FBN2 FBXL7 EDARADD SMG6 TCEA2 MSH5 GTF2B THBS2 CD3D PBRM1 SLC25A47 CFAP69 FZD2 TRIM49B | 1.51e-03 | 1392 | 188 | 19 | EFO_0005763 |
| Disease | Varicose veins | 1.53e-03 | 193 | 188 | 6 | HP_0002619 | |
| Disease | Alcoholic Intoxication, Chronic | 1.72e-03 | 268 | 188 | 7 | C0001973 | |
| Disease | Congenital disorder of glycosylation | 1.82e-03 | 38 | 188 | 3 | cv:C0282577 | |
| Disease | Jeune thoracic dystrophy | 2.14e-03 | 11 | 188 | 2 | C0265275 | |
| Disease | response to statin, myopathy | 2.14e-03 | 11 | 188 | 2 | EFO_0004145, GO_0036273 | |
| Disease | alanine measurement | 2.26e-03 | 86 | 188 | 4 | EFO_0009765 | |
| Disease | emphysema imaging measurement | 2.49e-03 | 146 | 188 | 5 | EFO_0007626 | |
| Disease | salicylurate measurement | 3.01e-03 | 13 | 188 | 2 | EFO_0010532 | |
| Disease | Short Rib-Polydactyly Syndrome | 3.01e-03 | 13 | 188 | 2 | C0036996 | |
| Disease | end stage renal disease (biomarker_via_orthology) | 3.36e-03 | 47 | 188 | 3 | DOID:783 (biomarker_via_orthology) | |
| Disease | urokinase plasminogen activator surface receptor measurement | 3.49e-03 | 14 | 188 | 2 | EFO_0010932 | |
| Disease | neuronal ceroid lipofuscinosis (implicated_via_orthology) | 3.49e-03 | 14 | 188 | 2 | DOID:14503 (implicated_via_orthology) | |
| Disease | Saldino-Noonan Syndrome | 3.49e-03 | 14 | 188 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 3.49e-03 | 14 | 188 | 2 | C0024507 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.78e-03 | 49 | 188 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | status epilepticus (biomarker_via_orthology) | 3.89e-03 | 100 | 188 | 4 | DOID:1824 (biomarker_via_orthology) | |
| Disease | hair color | 3.93e-03 | 311 | 188 | 7 | EFO_0003924 | |
| Disease | Proteinuria | 4.01e-03 | 15 | 188 | 2 | HP_0000093 | |
| Disease | response to varenicline, Nausea | 4.01e-03 | 15 | 188 | 2 | EFO_0600052, HP_0002018 | |
| Disease | amino acid measurement | CLTCL1 CHRM2 RYR2 OR8B3 NAV3 TRIM48 SLC52A1 RAD51AP2 LRP2 OR8B2 TRIM51G | 4.32e-03 | 678 | 188 | 11 | EFO_0005134 |
| Disease | colorectal mucinous adenocarcinoma | 4.57e-03 | 16 | 188 | 2 | EFO_0009361 | |
| Disease | Pre-Eclampsia | 4.57e-03 | 16 | 188 | 2 | C0032914 | |
| Disease | intraocular pressure measurement | 5.56e-03 | 509 | 188 | 9 | EFO_0004695 | |
| Disease | response to clozapine | 5.78e-03 | 18 | 188 | 2 | GO_0097338 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SCISCLNSNAMPRLR | 146 | Q86Y79 | |
| DCRENVIMSQILPCI | 316 | P30153 | |
| PLVFMSLVCALLNTC | 6 | P54793 | |
| ALISAQRCMICQGDI | 721 | Q86US8 | |
| NLRNLFPCGDSMVCI | 286 | Q9Y5B0 | |
| LLMRPIICICNDQFA | 481 | Q8WVB6 | |
| SQCFVLAVQRCPMAD | 386 | Q8IZF5 | |
| DDCLNRMIFAECSPN | 2111 | Q9NR48 | |
| RMCQSCVELDPATVA | 91 | P04234 | |
| IFCISPQRINMCGQI | 466 | Q4VNC0 | |
| FQIIMVCTPSLCFIT | 81 | Q9UKL4 | |
| PINQVCSEILLSRMC | 1006 | A4D0V7 | |
| AQPLAQRLCSMVCFS | 46 | P07307 | |
| DITQCFCLRATCIMN | 331 | Q9Y3Q7 | |
| VAQQCMICSSLPERI | 266 | Q969M2 | |
| CFEVLSPTKSCMLQA | 331 | Q96P50 | |
| NKMCRNCVRFPSSNL | 421 | P56282 | |
| AQPITCQGMFLCAVI | 1631 | Q5JWR5 | |
| MVLINTFCAPCIPNT | 406 | P08172 | |
| VNMFTCNSRDLLGCL | 851 | O95622 | |
| CELCPMANTTEYRTL | 1531 | Q75N90 | |
| LRCGQMIFAQALVCR | 76 | Q9Y4P1 | |
| CRSEAPTFRQMQCSE | 596 | P58397 | |
| SLIREITCQNMSCPQ | 701 | Q09MP3 | |
| SMAIEALPFQDCLCQ | 426 | Q9Y5P8 | |
| ALPFQDCLCQMLDLV | 431 | Q9Y5P8 | |
| CFNMGIRITQSLCFI | 436 | Q96AA3 | |
| CSPRMLNQCLESLVQ | 211 | Q9UL03 | |
| ATLRVALPSVMRFCC | 416 | Q9GZU1 | |
| ALPSVMRFCCCVAVI | 421 | Q9GZU1 | |
| CNVLLCSVVPSRRMD | 141 | Q5SQ64 | |
| QAMGIPFIIQCDLCL | 476 | Q86VD1 | |
| VNILMSLCQLRCLPF | 316 | Q14296 | |
| MSCRSRQPIICNDVS | 271 | Q96EL1 | |
| FLDLCFTTSCVPQML | 66 | O95918 | |
| FLSNLEETCPMTCIL | 1216 | Q86U86 | |
| MASFPETDFQICLLC | 1 | Q2Q1W2 | |
| RTLCCDMVCFLFITP | 136 | Q9P0N8 | |
| SCPMCQKEFAPRLTQ | 146 | Q6NZ36 | |
| SDFLMCLLCQPLTAV | 86 | P50391 | |
| CVCAALMRPLVVTAQ | 191 | O15427 | |
| ILTARQCFSSCHMPL | 521 | Q2TV78 | |
| FSDMRTCRVCPLNQL | 2246 | O95714 | |
| CPVCLQFFTLTLMNL | 101 | Q96N19 | |
| CEAFAMATLRQLPLC | 416 | Q9BYJ1 | |
| QEICCIAFAMQALEP | 421 | Q8TC71 | |
| RVEVMQQPCTCDFLT | 56 | Q9H252 | |
| TMQVSFVCQRCSQPL | 11 | Q14457 | |
| PRLCSFLRAACQVMA | 586 | Q8WVS4 | |
| NITPCENMECRDTTR | 1721 | Q8N6G6 | |
| RQAMSLEENLPCISC | 616 | O15031 | |
| CPRSQSQMIENVDVC | 131 | Q8IVL0 | |
| FMLDCNFQTTNSPVC | 326 | A0A1B0GTH6 | |
| EAVDACMACLRSPNT | 706 | Q14999 | |
| LSCLQSMPSVRCLQI | 36 | Q9UKB1 | |
| KVQCSPELRFFLCSM | 81 | Q14332 | |
| SFCGNPICMATLENL | 386 | P0DUQ1 | |
| QVTMCIGACPSQFRA | 236 | Q99988 | |
| NATTEFMCNNRRCIP | 2781 | P98164 | |
| CVSCMPYLLELNASQ | 166 | Q96M69 | |
| PFMNSQRAACICAEE | 176 | Q9BX93 | |
| DNRCFLFSICPSMAV | 321 | Q6P9B6 | |
| GCMLRLTFCSANIIN | 161 | Q8NGG8 | |
| ITNLMPLAACQALCT | 391 | Q5TGP6 | |
| TEMESQKQLCRPLTC | 741 | P78316 | |
| QMCNALCLFQVPESS | 111 | P0C7M6 | |
| TNMNDLFQVCPKSLC | 266 | Q92643 | |
| CIASVRNVCNIPDKM | 216 | Q7Z553 | |
| QPVQCKACRMEFCST | 131 | P50876 | |
| RSPMLDCSIADCLQF | 1011 | Q13349 | |
| NGLMVLQVDLPCFIC | 501 | Q14392 | |
| LSNVGADVQCCMRPA | 231 | Q9Y6A1 | |
| VQVLSCVLDPLLQMC | 471 | Q9Y2V7 | |
| CVLDPLLQMCTVSAS | 476 | Q9Y2V7 | |
| KVQCSPELRFFLCSM | 91 | O75084 | |
| SPKEAMLCFIQEACR | 241 | Q8N878 | |
| AFMLESVLDQCLPAC | 1131 | Q9NQ11 | |
| MNSPEARLCVAQCRD | 1 | Q6ZP68 | |
| QTINPLDVLCATMLC | 371 | Q9BX69 | |
| QAALQEVMFSSCLRC | 626 | Q9BX69 | |
| ILLNCVTLGMFRPCE | 91 | O43497 | |
| RLRMFPSLINCCTID | 2576 | Q8TD57 | |
| TCLEVISEMCPNLQA | 391 | Q9UKA2 | |
| RLCQDTPNVCLMLET | 176 | Q9UJT9 | |
| MCPIRATEDFNKLCS | 376 | P35555 | |
| ISDLNSLVFCCMRNA | 221 | Q5TCH4 | |
| LNVSIMAIPCLCSVA | 426 | Q49MI3 | |
| FCSMLCLLNSTVNPI | 381 | P21554 | |
| NCSQCEPITLELCMN | 451 | Q9Y5Q5 | |
| ICIKFCDMPVFENSR | 391 | Q92496 | |
| CLCPLEMNVAQEFQL | 196 | P42701 | |
| AETMSVLQDAPACCL | 881 | Q9Y4F3 | |
| ECDTITLNCPRNSDM | 56 | Q8WWZ3 | |
| FSCEPITLRMCQDLP | 26 | Q9NPG1 | |
| MLLARPAAVCDNARC | 86 | Q8NEG0 | |
| QLIVCQMSSTRCPTL | 306 | Q9C0D9 | |
| MRNELFLPCTTDQCS | 26 | Q6PJQ5 | |
| LMATIVAFCCARSQR | 551 | Q8IZU9 | |
| EIECVVGRNRSPCMQ | 326 | P33260 | |
| ARCNMEEPIRCAAVN | 361 | Q05BV3 | |
| SKVSCFMLQQIEEPC | 216 | Q13574 | |
| NELPFNVTKRMCCCT | 1751 | P35556 | |
| PMCRQFVQESFALCS | 306 | Q99675 | |
| CNLILGIMVEFCDNP | 626 | A5D8W1 | |
| RDQCILQLVMSAPCF | 256 | Q6T423 | |
| CLVSCFQQLMVETCS | 556 | P51172 | |
| EITFPKMVANCCRFL | 2186 | Q92736 | |
| ACCMEVANAVRASDP | 896 | O00411 | |
| QCPERLEVSCIQIMA | 161 | Q5VW36 | |
| CLSLFTERMCIQGSQ | 11 | O00591 | |
| ACACSTVPQMLVNLL | 71 | A4D2G3 | |
| GCMLRLTFCSANIIN | 161 | Q96RD0 | |
| CAQSMPCLVSFNILV | 96 | Q9Y5H4 | |
| MQLTRCCFVFLVQGS | 1 | O95157 | |
| LLMARLCFCADNVIP | 161 | P30953 | |
| AAMAINRCVAICNPF | 116 | Q8NH93 | |
| MNRRCCVLLLAFPIT | 136 | Q8NH93 | |
| FLDLCFTTSCVPQML | 66 | Q9GZK4 | |
| MELCARTFVPNSTEC | 566 | O43196 | |
| MNQETDPLCAECRLV | 491 | Q8IZ73 | |
| AICPRCSFSANMETL | 271 | Q7L3T8 | |
| PAVMTCIVSRQLCLR | 306 | P49848 | |
| PCTALCTVLMLNRTL | 126 | P78382 | |
| VVSQLIRCCNVSSRM | 2231 | Q93008 | |
| QCIKCMVALFSNCPV | 2386 | Q93008 | |
| ISQVFQRELTCPICM | 21 | Q8IWZ4 | |
| LQVFQGELICPLCMN | 6 | P0CI25 | |
| SNTRQCQALCMRLPE | 96 | Q13671 | |
| MACCLVAFFVLQRQP | 231 | Q9NQ40 | |
| EPTLLCNVTQDMLCT | 421 | P51649 | |
| NLALSDVLMCTACVP | 101 | P49683 | |
| LSNPVFTCIILAACM | 346 | Q9UIG8 | |
| NPVINDCCRGAMLSL | 481 | Q9Y4C2 | |
| MDPRLSTVRQTCCCF | 1 | Q13571 | |
| MASLETNCNFISFPC | 261 | Q6XZB0 | |
| IDLCCLMTISFNPSL | 586 | Q9H9A7 | |
| CVDNIRCNGLMTIVF | 586 | O14827 | |
| QMILSTVTVPFILCC | 271 | Q86VW1 | |
| VAQRAMCSARACPVA | 31 | O95177 | |
| DNMTCIIICFKPRNT | 496 | O15355 | |
| ERILGCCTSLMQAIQ | 821 | O00291 | |
| NCCRAFPVNMVVFVA | 281 | Q6Q0C1 | |
| ELDAVILTCQSMCFP | 666 | Q75T13 | |
| ESTCPMCSERLNAAQ | 1311 | Q8NEZ3 | |
| CTILTNCVFMTLSNP | 136 | Q9NY46 | |
| NKNVRMELCDVPSCS | 381 | Q01974 | |
| ENCQILVGCSMFAPL | 906 | Q9UHV7 | |
| PMLFALAICSQCSDI | 91 | P10155 | |
| VMCCNVPEARVFKAS | 616 | Q8TDI8 | |
| ACVARNPVINIASML | 606 | P13798 | |
| PTQEKIFAVLCMRCQ | 1041 | P51825 | |
| SATTQRFMNICFCCP | 456 | O95573 | |
| QDSCISMRQSGCLPL | 341 | P25054 | |
| FCLACVSAPLQFMAS | 216 | Q9NY35 | |
| VCICMNRISADTIFV | 291 | P53675 | |
| VRCSVFKCLPMILDN | 436 | Q86XI2 | |
| LLCTMALCNQVLSAP | 11 | P16619 | |
| PRLSVNCSEIICMFN | 286 | Q9BXT8 | |
| SFCGNPICMATLENL | 386 | O60810 | |
| ITNACFEPANQMVKC | 291 | P0DPH8 | |
| VPCQLSSSAMLICRR | 81 | I1YAP6 | |
| LQVFLRLEMCLQCPS | 721 | Q7Z2Z1 | |
| RLEMCLQCPSINEST | 726 | Q7Z2Z1 | |
| ETFLIDCRGPMNQCL | 231 | Q03405 | |
| ARMAETCVPVLRCNT | 211 | P07911 | |
| FSCRQLQCMAKPLSV | 331 | Q9HC29 | |
| LAMACCTSNVTFLPF | 121 | Q9NWF4 | |
| SRFCSNLCLPKQVQM | 216 | Q00403 | |
| LCCAISDMNTAQIVV | 126 | Q6ZVD7 | |
| LQVFQRALTCPICMN | 6 | Q9BSJ1 | |
| SFCGNPICMATLENL | 386 | P0DUQ2 | |
| LQVFQGELICPLCMN | 6 | P0CI26 | |
| ITNACFEPANQMVKC | 291 | P0DPH7 | |
| SDFLMCLLCQPLTAV | 86 | P0DQD5 | |
| SFCGNPICMATLENL | 386 | O60813 | |
| VRCMLQCPSVEVSFL | 2621 | Q709C8 | |
| ICSSCQLFEEAPTQM | 46 | Q86TA4 | |
| ALIYTCTVCRTQMPD | 36 | Q9Y5V0 | |
| LMRAQERETTCCGNP | 391 | P86452 | |
| LQVFQRELICPICMN | 6 | A0A3B3IT33 | |
| RTLALQCAMKDPQNC | 981 | Q9HCJ5 | |
| QKIQSCDMCVPFLTD | 101 | Q9BWM5 | |
| QNREMIDPDKFCSLC | 176 | Q9UL40 | |
| ALCLGNCMEVPNVAS | 626 | Q9H892 | |
| SAFRCVFQMLVVIPC | 101 | Q2M3R5 | |
| EPMTTFVVCNECGNR | 281 | Q15560 | |
| ITNACFEPANQMVKC | 291 | Q71U36 | |
| ITNACFEPANQMVKC | 291 | Q6PEY2 | |
| CRTDCNLLPMVIFSD | 2411 | Q92508 | |
| LQVFQRELICPICMN | 6 | A6NDI0 | |
| DVQERQMCNKRSCPV | 536 | P35442 | |
| MSIPCLVECVVNCQL | 1236 | Q9C0I4 | |
| MVCCPVNENAAALVV | 361 | Q9BZH6 | |
| PAVASANICNVVLMR | 206 | Q8TD22 | |
| ITNACFEPANQMVKC | 291 | P68363 | |
| CVECFERSVKINPMQ | 546 | Q6P3X3 | |
| MCEQAVTAFLKCSQP | 871 | Q9P2L0 | |
| MLLACCLSRFITANQ | 231 | P41732 | |
| DCQPSALNCFVEAMS | 2666 | Q9Y4A5 | |
| ITNACFEPANQMVKC | 291 | Q9BQE3 | |
| ITNACFEPANQMVKC | 291 | P68366 | |
| PVPSACFRNICKQMT | 881 | Q9P1Q0 | |
| LVAVSNSVPQDICCM | 116 | Q8NI36 | |
| RTLALQCAMKDPQNC | 756 | Q9H7M6 | |
| SQAMRCFPKVAINIC | 596 | Q86W24 |